Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Chinook Energy Inc. Common CNKEF



GREY:CNKEF - Post by User

Comment by CanadianFemmeon Jun 14, 2017 7:14am
159 Views
Post# 26359987

RE:RE:RE:Canaccord initiation - 60 c target

RE:RE:RE:Canaccord initiation - 60 c targetThanks templetooth for the instructions, seems like another user Graphene posted the entire report here. But I was able to find it on investorvillage as well and downloaded a copy for reference.

To reciprocate, my best stock idea is actually not in Oil & Gas and it is currently also my retirement plan :) It's a clinical stage pharmaceutical company called Aurinia Pharmaceuticals (AUPH). It also trades on TSX as AUP.TO. I have done extensive research into this company. They have one drug in the pipeline right now for Lupus, phase 3, expected to be completed by end of 2019. I've been holding it since the beginning of the year when it was at $3.33, currently trading around $6. If it passes phase 3 and gets FDA approval, it will be the first Lupus drug to get approved in 50 years. Estimated Buyout prices for the company range from $45 - $95, depending on when they get acquired....it's an estimated 6-7 bagger from here.

Financially they have over $200 Million in cash to get them through the next few years of research and development. Bob Duggan, a well-known biotech investor just bought over 5 million shares which is a huge vote of confidence. The CEO, Richard Glickman, sold his previous company for over $900 Million and he has an excellent track record of getting the job done. Many investors say this is as de-risked an investment in biotech as it gets, and these companies only come around once in many people's lives. So I've put a bunch of money in the drawer and closed it for now. I will re-open the drawer in 2020 and hope to retire :) Good luck with your investments!
<< Previous
Bullboard Posts
Next >>